Cabot Corporation (CBT) vs Calumet, Inc. (CLMT)

Cabot Corporation and Calumet, Inc. are both Specialty Chemicals companies. Cabot Corporation and Calumet, Inc. are of similar size ($3.8B and $3.8B). Calumet, Inc. has negative trailing earnings, so its P/E is not meaningful; Cabot Corporation trades at 17.4×. Calumet, Inc. grew revenue faster over the last twelve months: 12.8% against 0.83%. Cabot Corporation has the higher net margin (5.66% vs −2.98%) and the higher return on invested capital (10.8% vs 2.03%). Across the 19 metrics below, Cabot Corporation leads on 13 and Calumet, Inc. on 6.

Valuation

Metric CBT CLMT Specialty Chemicals median
P/E 17.42 n/m 24.46
P/S 1.00 0.83 1.64
P/B 2.12 n/m 1.88
Price to free cash flow 17.56 51.99 19.15
EV/EBITDA 7.07 47.88 12.87
EV/Sales 1.27 1.40 1.88
Earnings yield 5.74% (3.55%) 2.42%
Free cash flow yield 5.70% 1.92% 2.25%

Profitability

Metric CBT CLMT Specialty Chemicals median
Gross margin 21.61% 6.57% 27.84%
Operating margin 12.74% 1.03% 5.64%
Net margin 5.66% (2.98%) 4.19%
Free cash flow margin 5.72% 1.60% 3.49%
Return on equity 12.20% 12.74% 2.34%
Return on assets 5.41% (4.90%) 0.45%
Return on invested capital 10.77% 2.03% 3.21%

Growth

Metric CBT CLMT Specialty Chemicals median
Revenue growth (TTM) 0.83% 12.80% 6.39%
EPS growth (last fiscal year) (10.42%) 85.39% (9.77%)
Revenue growth, 5-year CAGR 7.27% 12.77% 6.33%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CBT CLMT Specialty Chemicals median
Debt to equity 0.71 (2.41) 0.59
Current ratio 2.16 0.84 2.28
Net debt to EBITDA 1.13 7.36 2.03

Dividend

Metric CBT CLMT Specialty Chemicals median
Dividend yield 2.53% — 1.80%
Payout ratio 0.44 — 0.40

Size

Metric CBT CLMT Specialty Chemicals median
Market cap 3.75b 3.81b 2.08b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack